ReviewFrontiers in oncology2026

From dual inhibition to precision selectivity: the molecular rationale and clinical evolution of next-generation PARP1-selective inhibitors in solid tumors.

Maha M Ayoub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.